Oxford University’s coronavirus vaccine opens for clinical trial on humans

ChAdOx1 nCoV-19, the COVID-19 vaccine developed by Oxford, is based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein.

from The Hindu - Science https://ift.tt/2WLGD2N

Comments

Popular posts from this blog

Seismic study reveals key reason why Patagonia is rising as glaciers melt

New method to detect and visualize sperm cells recovered from forensic evidence